How to use C-reactive protein

被引：21
作者：
Dyer, Emma M. [1 ]
Waterfield, Thomas [2 ]
Baynes, Hannah [3 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland
[3] Kings Coll London, Sch Med Educ, London, England
来源：
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION | 2019年 / 104卷 / 03期
关键词：
ANTIBIOTIC-THERAPY;
D O I：
10.1136/archdischild-2018-315079
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
A 3-month-old baby is brought to the paediatric emergency department by their parents because of a fever. You decide to check their inflammatory markers. Their C-reactive protein (CRP) level comes back as 20 mg/L. Does this affect whether or not you start antibiotic therapy? Does it influence your decision to admit or discharge the patient? CRP is a commonly used biochemical test and yet its use is constantly debated and challenged. We look at the current evidence and suggest the best way to use this test in clinical practice.
引用
收藏
页码：150 / 153
页数：4
相关论文
共 50 条
[31]   Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study [J].
Luís M Coelho ;
Jorge IF Salluh ;
Márcio Soares ;
Fernando A Bozza ;
JuanCarlos R Verdeal ;
Hugo C Castro-Faria-Neto ;
José Roberto Lapa e Silva ;
Patrícia T Bozza ;
Pedro Póvoa .
Critical Care, 16
[32]   C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection [J].
Ehl, S ;
Gering, B ;
Bartmann, P ;
Hogel, J ;
Pohlandt, F .
PEDIATRICS, 1997, 99 (02) :216-221
[33]   Procalcitonin and C-reactive protein levels as diagnostic tools in febrile patients admitted to a General Internal Medicine ward [J].
Ruiz-Esteban, Raul ;
Relea Sarabia, Pilar ;
Garcia Delgado, Emilio ;
Barros Aguado, Carlos ;
Amerigo Cuervo-Arango, Jose ;
Varela, Manuel .
CLINICAL BIOCHEMISTRY, 2012, 45 (1-2) :22-25
[34]   Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD [J].
Bafadhel, Mona ;
Clark, Tristan W. ;
Reid, Carlene ;
Medina, Marie-jo ;
Batham, Sally ;
Barer, Michael R. ;
Nicholson, Karl G. ;
Brightling, Christopher E. .
CHEST, 2011, 139 (06) :1410-1418
[35]   Patterns of C-reactive protein ratio predicts outcomes in healthcare-associated pneumonia in critically ill patients with cancer [J].
Rabello, Ligia S. C. F. ;
Povoa, Pedro ;
Lapa e Silva, Jose R. ;
Azevedo, Luciano C. P. ;
da Silva Ramos, Fernando Jose ;
Lisboa, Thiago ;
Soares, Marcio ;
Salluh, Jorge I. F. .
JOURNAL OF CRITICAL CARE, 2017, 42 :231-237
[36]   Comparative Impact of C-Reactive Protein Testing in Hospitalized Patients with Acute Respiratory Tract Infection: A Retrospective Cohort Study [J].
Giannini, Olivier ;
Del Giorno, Rosaria ;
Zasa, Anna ;
Gabutti, Luca .
ADVANCES IN THERAPY, 2019, 36 (11) :3186-3195
[37]   Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients [J].
Hoeboer, Sandra H. ;
Groeneveld, A. B. Johan .
PLOS ONE, 2013, 8 (06)
[38]   Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits [J].
Chang, Chih-Hao ;
Tsao, Kuo-Chien ;
Hu, Han-Chung ;
Huang, Chung-Chi ;
Kao, Kuo-Chin ;
Chen, Ning-Hung ;
Yang, Cheng-Ta ;
Tsai, Ying-Huang ;
Hsieh, Meng-Jer .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :767-774
[39]   Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy [J].
C. Elsing ;
S. Ernst ;
N. Kayali ;
W. Stremmel ;
S. Harenberg .
Infection, 2011, 39
[40]   Lipopolysaccharide binding protein, interleukin-6 and C-reactive protein in acute gastrointestinal infections: value as biomarkers to reduce unnecessary antibiotic therapy [J].
Elsing, C. ;
Ernst, S. ;
Kayali, N. ;
Stremmel, W. ;
Harenberg, S. .
INFECTION, 2011, 39 (04) :327-331
12345